semaglutide a glp-1 Liraglutide vs vs GLP-1 for Weight Loss Semaglutide GLP-1 for Medical Weight

Two additional trials, CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) (canagliflozin) and DAPA-HF (Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction) (dapagliflozin), evaluated alternative primary outcomes of renal events and HF events in patients with CKD stage 2/3 and chronic HF, respectively, and analyzed 3P-MACE as a secondary endpoint

The World Health Organization (WHO) requested these reviews to help shape upcoming recommendations on using these medications for obesity treatment

Emerging clinical experiences and anecdotal reports are starting to shape a new narrative

PMID: 6328354

GLP-1 drugs like Ozempic and Wegovy have become increasingly common for adults for both diabetes management and weight loss